Bioarray: Bioarray Granted Patent for Lead Breast Cancer Predictive Test

This test exemplifies the impact of advanced molecular testing on breast cancer treatment. FARMINGTON, Conn. (PRWEB) December 04, 2017 Bioarray Genetics, Inc.("Bioarray" or the "Company") announced today that the Company has been granted a US patent supporting its lead breast cancer predictive test. The US Patent & Trademark Office has issued US Patent No. [...]